Cellular Phototoxicity Evoked Through the Inhibition of Human ABC Transporter ABCG2 by Cyclin-dependent Kinase Inhibitors In vitro

被引：0
|
作者：
Ran An
Yuichiro Hagiya
Ai Tamura
Shanshan Li
Hikaru Saito
Daisuke Tokushima
Toshihisa Ishikawa
机构：
[1] Tokyo Institute of Technology,Department of Biomolecular Engineering, Graduate School of Bioscience and Biotechnology
[2] NEC Corporation,undefined
来源：
Pharmaceutical Research | 2009年 / 26卷
关键词：
ABCG2 (BCRP/MXR); cyclin-dependent kinase inhibitor; pheophorbide a; phototoxicity; porphyrin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：449 / 458
页数：9
相关论文
共 50 条
  • [1] Cellular Phototoxicity Evoked Through the Inhibition of Human ABC Transporter ABCG2 by Cyclin-dependent Kinase Inhibitors In vitro
    An, Ran
    Hagiya, Yuichiro
    Tamura, Ai
    Li, Shanshan
    Saito, Hikaru
    Tokushima, Daisuke
    Ishikawa, Toshihisa
    [J]. PHARMACEUTICAL RESEARCH, 2009, 26 (02) : 449 - 458
  • [2] Inhibition of Breast Cancer Resistance Protein (BCRP/ABCG2) by Purine Cyclin-dependent Kinase Inhibitors In Vitro and In Situ
    Hofman, Jakub
    Ahmadimoghaddam, Davoud
    Hahnova, Lenka
    Ceckova, Martina
    Staud, Frantisek
    [J]. DRUG METABOLISM REVIEWS, 2010, 42 : 33 - 33
  • [3] Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2:: development of in vitro high-speed screening systems
    Tamura, Ai
    An, Ran
    Hagiya, Yuichiro
    Hoshijima, Kazuyuki
    Yoshida, Takashi
    Mikuriya, Kenta
    Ishikawa, Toshihisa
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (03) : 255 - 272
  • [4] Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor
    Seamon, Jennifer A.
    Rugg, Catherine A.
    Emanuel, Stuart
    Calcagno, Anna Maria
    Ambudkar, Suresh V.
    Middleton, Steven A.
    Butler, Jeannene
    Borowski, Virna
    Greenberger, Lee M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2006, 5 (10) : 2459 - 2467
  • [5] Cyclin-Dependent Kinase 5 Inhibitors: Inhibition of Dopamine Transporter Activity
    Price, David A.
    Sorkin, Alexander
    Zahniser, Nancy R.
    [J]. MOLECULAR PHARMACOLOGY, 2009, 76 (04) : 812 - 823
  • [6] Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro
    Cihalova, Daniela
    Ceckova, Martina
    Kucera, Radim
    Klimes, Jiri
    Staud, Frantisek
    [J]. BIOCHEMICAL PHARMACOLOGY, 2015, 98 (03) : 465 - 472
  • [7] CHARACTERIZATION AND CLASSIFICATION OF CDK INHIBITORS BY QSAR ANALYSIS OF HUMAN ABC TRANSPORTER ABCG2
    Saito, Hikaru
    Hirano, Hiroyuki
    Hirono, Shuichi
    Tokushima, Daisuke
    Ishikawa, Toshihisa
    [J]. DRUG METABOLISM REVIEWS, 2007, 39 : 78 - 79
  • [8] In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs
    Tamura, Ai
    Onishi, Yuko
    An, Ran
    Koshiba, Shoko
    Wakabayashi, Kanako
    Hoshijima, Kazuyuki
    Priebe, Waldemar
    Yoshida, Takashi
    Kometani, Satoshi
    Matsubara, Takayoshi
    Mikuriya, Kenta
    Ishikawa, Toshihisa
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (06) : 428 - 440
  • [9] Cyclin-dependent kinase inhibitors and human cancer
    Kamb, A
    [J]. CYCLIN DEPENDENT KINASE (CDK) INHIBITORS, 1998, 227 : 139 - 148
  • [10] Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
    Nagai, Shinjiro
    Takenaka, Kazumasa
    Nachagari, Deepa
    Rose, Charles
    Domoney, Kali
    Sun, Daxi
    Sparreboom, Alex
    Schuetz, John D.
    [J]. CANCER RESEARCH, 2011, 71 (05) : 1781 - 1791
12345